LT3300482T - Prg4 panaudojimas dinaminio regos aštrumo pagerinimui ir aukštesnės eilės aberacijų sumažinimui - Google Patents

Prg4 panaudojimas dinaminio regos aštrumo pagerinimui ir aukštesnės eilės aberacijų sumažinimui

Info

Publication number
LT3300482T
LT3300482T LTEPPCT/US2016/033248T LT16033248T LT3300482T LT 3300482 T LT3300482 T LT 3300482T LT 16033248 T LT16033248 T LT 16033248T LT 3300482 T LT3300482 T LT 3300482T
Authority
LT
Lithuania
Prior art keywords
prg4
higher order
visual acuity
order aberrations
dynamic visual
Prior art date
Application number
LTEPPCT/US2016/033248T
Other languages
English (en)
Inventor
Benjamin Sullivan
Edward Truitt
Original Assignee
Lubris Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubris Llc filed Critical Lubris Llc
Publication of LT3300482T publication Critical patent/LT3300482T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrane Compounds (AREA)
  • Prostheses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
LTEPPCT/US2016/033248T 2015-05-19 2016-05-19 Prg4 panaudojimas dinaminio regos aštrumo pagerinimui ir aukštesnės eilės aberacijų sumažinimui LT3300482T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562163753P 2015-05-19 2015-05-19
PCT/US2016/033248 WO2016187414A1 (en) 2015-05-19 2016-05-19 Use of prg4 to improve dynamic visual acuity and higher order aberrations

Publications (1)

Publication Number Publication Date
LT3300482T true LT3300482T (lt) 2021-10-25

Family

ID=57320651

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2016/033248T LT3300482T (lt) 2015-05-19 2016-05-19 Prg4 panaudojimas dinaminio regos aštrumo pagerinimui ir aukštesnės eilės aberacijų sumažinimui

Country Status (14)

Country Link
US (1) US11666529B2 (lt)
EP (1) EP3300482B1 (lt)
JP (2) JP7291459B2 (lt)
CY (1) CY1124538T1 (lt)
DK (1) DK3300482T3 (lt)
ES (1) ES2893304T3 (lt)
HR (1) HRP20211589T1 (lt)
HU (1) HUE056409T2 (lt)
LT (1) LT3300482T (lt)
MA (1) MA42148A (lt)
PL (1) PL3300482T3 (lt)
PT (1) PT3300482T (lt)
SI (1) SI3300482T1 (lt)
WO (1) WO2016187414A1 (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015060935A1 (en) 2013-10-22 2015-04-30 Lubris, Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
RU2017129880A (ru) 2015-01-26 2019-03-04 ЛУБРИС ЭлЭлСи Применение prg4 в качестве противовоспалительного средства
BR112020025148A2 (pt) * 2018-06-21 2021-03-09 Lubris Llc Lubricina para uso na cicatrização de feridas
CN113573724B (zh) * 2019-01-15 2025-12-19 康奈尔大学 重组润滑素和组合物以及其使用方法
US20230127949A1 (en) * 2020-02-24 2023-04-27 Novartis Ag Purification of recombinantly produced polypeptides

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433142B1 (en) 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins
US6960562B2 (en) 1999-04-23 2005-11-01 Rhode Island Hospital, A Lifespan Partner Tribonectin polypeptides and uses thereof
US7001881B1 (en) 1999-04-23 2006-02-21 Rhode Island Hospital Tribonectins
US7415381B2 (en) 2003-01-09 2008-08-19 Rhode Island Hospital, A Lifespan Partner Joint friction sensing
WO2005000331A2 (en) 2003-06-04 2005-01-06 Mucosal Therapeutics, Inc. Compositions for the treatment and prevention of degenerative joint disorders
WO2005102363A2 (en) 2004-04-20 2005-11-03 Mucosal Therapeutics Llc Methods of promoting cartilage healing or cartilage integration
EP1778360A2 (en) 2004-07-23 2007-05-02 Mucosal Therapeutics LLC Compositions and methods for viscosupplementation
WO2006060473A2 (en) 2004-12-03 2006-06-08 Mucosal Therapeutics Llc Methods of treatment of injured or diseased joints with lubricin compositions
US20070111327A1 (en) 2005-05-05 2007-05-17 Jay Gregory D Methods of detecting lubricin
US8144631B2 (en) 2006-12-13 2012-03-27 Cisco Technology, Inc. Interconnecting IP video endpoints with reduced H.320 call setup time
WO2008143816A1 (en) 2007-05-15 2008-11-27 Mucosal Therapeutics Compositions and methods for reducing friction between the surface of tendons or other soft tissues
US20090068247A1 (en) 2007-09-12 2009-03-12 Mucosal Therapeutics Biocompatible devices coated with a tribonectin and methods for their production
US20090104148A1 (en) 2007-09-18 2009-04-23 Jay Gregory D Treatment and prevention of joint disease
US8506944B2 (en) 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
HUE024146T2 (en) 2008-05-07 2016-02-29 Univ California Medical filling and enrichment of eye surface lubrication
US8980840B2 (en) 2009-01-13 2015-03-17 Schepens Eye Research Institute Therapeutic modulation of vaginal epithelium boundary lubrication
CA2762989C (en) 2009-05-22 2021-04-13 Benjamin Sullivan Prg4 for treatment of oral cavity boundary lubrication disorders
WO2011019963A2 (en) 2009-08-13 2011-02-17 Singularis, Inc. Prg4 treatment for interstitial cystitis
WO2011091000A2 (en) 2010-01-19 2011-07-28 Singularis, Inc. Oral care compositions and methods
ES2423914T3 (es) 2010-07-30 2013-09-25 Novartis Ag Lentes de hidrogel de silicona con superficies ricas en agua
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
US20130116186A1 (en) 2011-10-04 2013-05-09 Rhode Island Hospital, A Lifespan Partner Lubricin injections to maintain cartilage health
WO2015060935A1 (en) 2013-10-22 2015-04-30 Lubris, Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
EP3074022B1 (en) 2013-11-26 2022-03-30 Lubris LLC Compositions and methods for inhibiting intercellular interactions
US20180161393A1 (en) 2015-01-26 2018-06-14 Lubris Llc Prg4 for treating gout and its symptoms
RU2017129880A (ru) 2015-01-26 2019-03-04 ЛУБРИС ЭлЭлСи Применение prg4 в качестве противовоспалительного средства
US20170312335A1 (en) 2015-12-30 2017-11-02 Lubris Llc Topical use of prg4 for treatment of allergy and symptoms of inflammation

Also Published As

Publication number Publication date
PL3300482T3 (pl) 2022-01-03
MA42148A (fr) 2018-04-04
EP3300482A1 (en) 2018-04-04
SI3300482T1 (sl) 2021-11-30
EP3300482B1 (en) 2021-07-14
JP2018515534A (ja) 2018-06-14
ES2893304T3 (es) 2022-02-08
EP3300482A4 (en) 2019-02-13
DK3300482T3 (da) 2021-10-18
HRP20211589T1 (hr) 2022-01-07
HUE056409T2 (hu) 2022-02-28
CY1124538T1 (el) 2022-07-22
JP2021167318A (ja) 2021-10-21
US11666529B2 (en) 2023-06-06
US20180140546A1 (en) 2018-05-24
PT3300482T (pt) 2021-10-15
WO2016187414A1 (en) 2016-11-24
JP7291459B2 (ja) 2023-06-15

Similar Documents

Publication Publication Date Title
IL273688A (en) Evaluation and treatment of bradykinin-mediated disorders
GB2551642B (en) Methods and compositions relating to microbial treatment and diagnosis of disorders
ZA201801511B (en) Flavonoid compositions and methods of use
PL3349783T3 (pl) Kompozycje i sposoby do leczenia chorób
GB201716169D0 (en) Methods and compositions relating to microbial treatment and diagnosis of skin disorders
SG11201601412XA (en) Compositions and methods for the treatment of presbyopia
EP3680856C0 (en) ASSESSMENT OF DENTAL TREATMENTS AND PROCEDURES BASED ON PHOTOGRAPHS
ZA201705260B (en) Fungal strains and methods of use
SG11201701377YA (en) Compositions and methods to treat vision disorders
ZA201802329B (en) Hppd variants and methods of use
SG11201708114SA (en) Ophthalmic compositions and methods of use therefor
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
PT3300482T (pt) Uso de prg4 para melhorar a acuidade visual dinâmica e as aberrações de ordem superior
PT3397364T (pt) Elementos estruturados e métodos de utilização
IL246587A0 (en) Preparations for use in the treatment of allergic conditions
GB2535562B (en) Hydrogel compositions and their use in the treatment of symptoms induced by hypertrophic scars
IL252070A0 (en) Preparations containing apoequrin and methods of using them to treat neuritis
GB2546965B (en) Improvements in and relating to the treatment of arthrofibrosis
GB2527909B (en) Improvements in and relating to imaging of the eye
GB201516437D0 (en) Compositions and methods relating to the treatment of disease
GB201516303D0 (en) Compositions and methods relating to the treatment of diseases
HK1220029B (en) Improvements in and relating to imaging of the eye
HK1197719A (en) Improvements in and relating to ophthalmoscopes
HK1197719B (en) Improvements in and relating to ophthalmoscopes
GB201415915D0 (en) Improvements in and Relating to ophthalmoscopes